| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.057 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.054 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.014 | 0.8 |